Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

By Tung N.   Berkowitz R.   Matulonis U.   Quartulli M.   Seiden M.   Kim Y.   Niloff J.   Cannistra S.A.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

Association between CHFR methylation and chemosensitivity of paclitaxel in advanced gastric cancer

By Wang Mingming   Shen Lin   Deng Dajun  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-2

Humana Press, Inc

Access to resources Recommend Favorite

Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen

By Raderer M.   Kornek G.V.   Hejna M.H.L.   Miholic J.   Weinlaender G.   Brodowicz T.   Fiebiger W.C.C.   Valencak J.B.   Scheithauer W.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1128-1130

Elsevier

Access to resources Recommend Favorite

Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus

By Montagut C.   Marmol M.   Rey V.   Ordi J.   Pahissa J.   Rovirosa A.   Gascon P.   Mellado B.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 458-461

Elsevier

Access to resources Recommend Favorite

Successful treatment of advanced gastric cancer by surgical resection following combination chemotherapy with oral S-1 and biweekly paclitaxel

By Nakajo Akihiro   Natsugoe Shoji   Hokita Shuichi   Ishigami Sumiya   Takatori Hiroyuki   Arigami Takaaki   Uenosono Yoshikazu   Aridome Kuniaki   Aikou Takashi  

Gastric Cancer, Vol. 10, Iss. 1, 2007-02 ,pp. : 58-62

Springer Publishing Company

Access to resources Recommend Favorite